Shun Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shun Huang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Bo Liu
State Key Laboratory of General Artificial Intelligence, School of Intelligence Science and Technology, Peking University, Beijing, China
1 shared publication - Bosong Huang
Independent Researcher, Brisbane, Australia
1 shared publication - Cheng Ding
Georgia Institute of Technology
1 shared publication - Chenyang He
Nanjing University of Aeronautics and Astronautics, Nanjing, Jiangsu, China
1 shared publication - Daoqiang Zhang
Nanjing University of Aeronautics and Astronautics
1 shared publication Gao‐Fei Du
Key Laboratory of Laboratory Diagnostics Medical Technology School Xuzhou Medical University Xuzhou China
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (87) , e78496
Engineered Mammalian Cell Membrane‐Coated Nanoparticles for Targeted Delivery of Antibiotics to Eradicate Drug‐Resistant Gram‐Negative Bacteria
The increasing prevalence of drug‐resistant bacteria poses a major global health threat. The outer membrane of Gram‐negative bacteria acts as a natural barrier that limits the penetration of antimicrobial agents, reducing therapeutic efficacy. To overcome the outer membrane barrier, we developed a biomimetic antibiotic‐delivery system composed of ampicillin‐loaded mesoporous polydopamine (MPDA) nanoparticles coated with TLR4‐overexpressing cell membranes (MPDA‐Amp‐cmTLR4). The engineered membrane promoted LPS‐sensitive association with Gram‐negative bacteria and concentrated the nanoparticles at the bacterial envelope. The targeted MPDA‐Amp‐cmTLR4 nanoparticles substantially reduced the required Amp concentration and markedly inhibited drug‐resistant Escherichia coli , whereas matched non‐targeted formulations showed limited activity. NIR‐induced photothermal heating provided an additional enhancement in the externally accessible wound model by accelerating local drug release and increasing bacterial stress. Proteomic and biochemical analyses indicated that the treatment disrupted cell‐wall and membrane homeostasis and induced an oxidative‐stress response. In murine models, MPDA‐Amp‐cmTLR4 accumulated at infected lungs, reduced systemic bacterial burdens and inflammatory responses in sepsis, and promoted the healing of infected wounds. This biomimetic strategy therefore enhances the local efficacy of antibiotics against drug‐resistant Gram‐negative bacteria while reducing the required bulk antibiotic concentration.
- 17 September 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (87) , e78496
Open AccessEngineered Mammalian Cell Membrane‐Coated Nanoparticles for Targeted Delivery of Antibiotics to Eradicate Drug‐Resistant Gram‐Negative Bacteria
The increasing prevalence of drug‐resistant bacteria poses a major global health threat. The outer membrane of Gram‐negative bacteria acts as a natural barrier that limits the penetration of antimicrobial agents, reducing therapeutic efficacy. To overcome the outer membrane barrier, we developed a biomimetic antibiotic‐delivery system composed of ampicillin‐loaded mesoporous polydopamine (MPDA) nanoparticles coated with TLR4‐overexpressing cell membranes (MPDA‐Amp‐cmTLR4). The engineered membrane promoted LPS‐sensitive association with Gram‐negative bacteria and concentrated the nanoparticles at the bacterial envelope. The targeted MPDA‐Amp‐cmTLR4 nanoparticles substantially reduced the required Amp concentration and markedly inhibited drug‐resistant Escherichia coli , whereas matched non‐targeted formulations showed limited activity. NIR‐induced photothermal heating provided an additional enhancement in the externally accessible wound model by accelerating local drug release and increasing bacterial stress. Proteomic and biochemical analyses indicated that the treatment disrupted cell‐wall and membrane homeostasis and induced an oxidative‐stress response. In murine models, MPDA‐Amp‐cmTLR4 accumulated at infected lungs, reduced systemic bacterial burdens and inflammatory responses in sepsis, and promoted the healing of infected wounds. This biomimetic strategy therefore enhances the local efficacy of antibiotics against drug‐resistant Gram‐negative bacteria while reducing the required bulk antibiotic concentration.
- Open Access
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 11050-11060
CAP: Towards PPG Universal Representation Learning with Patient-level Supervision
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 11050-11060
Open AccessCAP: Towards PPG Universal Representation Learning with Patient-level Supervision
- Open Access
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 10877-10888
ECGFlowCMR: Pretraining with ECG-Generated Cine CMR Helps Cardiac Disease Classification and Phenotype Prediction
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 10877-10888
Open AccessECGFlowCMR: Pretraining with ECG-Generated Cine CMR Helps Cardiac Disease Classification and Phenotype Prediction